Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study. Infectious Diseases and Therapy, 9(1): 41-52.

In by AHF

Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Chronic Kidney Disease Risk Score in HIV-Infected Patients in the USA. HIV Medicine, 21: 299-308.
Benchmarking HIV Quality Measures in the US OPERA HIV Cohort. Open Forum Infectious Diseases, 6(10): 1-9.
Download
File Type: pdf
Categories: 2019
Tags: 2015-2019